--2024/Q3-- / 86.718M--
--2024/Q2-- / 87.667M--
May 9, 20242024/Q186.604M / 79.499M--
Mar 21, 20242023/Q474.197M / 78.675M--
Nov 9, 20232023/Q381.500M / 73.513M--
CA Stock MarketDetailed Quotes
GUD Knight Therapeutics Inc
- 5.590
- -0.100-1.76%
15min DelayMarket Closed Jul 24 16:00 ET
566.69MMarket Cap-34937P/E (TTM)
5.690High5.560Low55.37KVolume5.690Open5.690Pre Close310.10KTurnover6.22052wk High0.10%Turnover Ratio101.38MShares4.35052wk Low-0.16EPS TTM296.99MFloat Cap11.030Historical HighLossP/E (Static)53.13MShs Float3.510Historical Low-0.16EPS LYR2.29%Amplitude--Dividend TTM0.74P/B1Lot Size--Div YieldTTM
Knight Therapeutics Inc Key Stats
Knight Therapeutics Inc Earnings Date
Currency: CAD
Period
Q1 FY2024 Earnings
May 9, 2024
Revenue(YoY)
86.60M
+4.85%EPS(YoY)
-0.04
0.00%Knight Therapeutics Inc Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: CAD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Heat List
CA
Overall
Symbol
Latest Price
%Chg